NDA Group will be attending and presenting at this year’s Nordic Life Science Days, the largest Nordic partnering conference dedicated to the life science industry, 10-12 September in Stockholm, Sweden.
If you are planning to attend this year’s NLS days, we would really like to meet up with you. Markku Toivonen (MD, PhD), Scientific Director NDA Advisory Board, Thomas Lönngren, NDA Strategic Advisor and Former Executive Director of the European Medicines Agency (EMA) and Terese Johansson (PhD), NDA Consultant, are available for meetings during the event to discuss how a tailored global drug development strategy can maximize your product´s potential value and accelerate time to drug approval. To book a meeting with them please register here.
If you would like to book a meeting with us on a different date click here.
Dr Markku Toivonen will also present in Super Session 2 – Return on Engagement: Patient engagement as a strategic imperative in medicines development on 11th September 11:30-12:30 at Plenary Room Level 5. This session will look at what patient engagement actually means in practical terms, and its impact as a business development tool, drawing on concrete good practice examples from the rare diseases community and personalised medicines.
We are looking forward seeing you at the event.